Transcriptional profiling identified a metabolic injury signature (e.g., IDO1, NOS2, DUOX2) that differentiated inflamed from non-inflamed tissue in Crohn’s disease patients, associating mitochondrial dysfunction and Bacteroides dysbiosis with IBD progression via disrupted host-microbe metabolic interactions. Here, IDO1 is linked to inflammatory bowel disease.